Open Access Case Report

Psychosis in Parkinson Disease

Mervat Wahba*

Associate Professor, USA

Corresponding Author

Received Date: Novmber 07, 2018;  Published Date: November 15, 2018

Abstract

Parkinson disease (PD) affects 1 million Americans with the number anticipated to double worldwide by 2030. There is a growing interest in psychosis and Parkinson’s disease [PD], and its impact on treatment. Hallucinations and psychosis occur at any time during the course of Parkinson’s disease. The mechanisms underlying drug-induced psychosis in Parkinson disease are not fully understood. Step-by-step approach and excluding other causes for delirium and psychosis such as infection should be considered.

Citation
Signup for Newsletter
Scroll to Top